MS Connect
  • Saved

1yr
Balancing Efficacy and Safety in Relapsing Multiple Sclerosis: What is Your Optimal Approach?

In the treatment of relapsing multiple sclerosis (RMS), finding the right balance between efficacy and safety remains a challenge. Advances in monotherapy options have shown significant efficacy in reducing relapse rates and slowing disease progression. However, these benefits must be weighed against potential risks, including in some cases, the heightened risk of progressive multifocal leukoencephalopathy (PML).

Recent studies emphasize the importance of patient-centered approaches when managing RMS. Tailoring treatment to individual patient profiles—including disease activity, prior treatment history, and risk factors—can optimize outcomes while mitigating risks. As the therapeutic landscape evolves, clinicians must continuously reassess the benefit-risk ratio of treatments like natalizumab to ensure the best outcomes for their patients.

How do you balance the efficacy and safety of treatment options in RMS? What factors most influence your decision-making process when choosing monotherapy for your patients?

Show More Comments

  • Saved

1yr
"My sister wants to kill me": A case report and systematic review of literature of co-occurring multiple sclerosis and psychosis - PubMed

"My sister wants to kill me": A case report and systematic review of literature of co-occurring multiple sclerosis and psychosis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39100118/

This case highlights the importance of conducting a magnetic resonance imaging (MRI) brain not only for initial onset psychosis but also for any sudden changes in patients who have had...

A case report and literature review reveal co-occurring psychosis in multiple sclerosis patients, emphasizing the need for MRI evaluations and prompt management to enhance treatment adherence and patient outcomes.

  • Saved

1yr
Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies - PubMed

Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38626023/

This study indicates that MRI can be used to predict the cognitive decline, disability progression, and disease progression in MS patients over time.

This study demonstrates that MRI effectively predicts cognitive decline, disability progression, and disease progression in Multiple Sclerosis patients by evaluating lesions and structural changes in the central nervous system.

  • Saved

1yr
Consensus quality indicators for monitoring multiple sclerosis - PubMed

Consensus quality indicators for monitoring multiple sclerosis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38585674/

Multiple sclerosis (MS) as a chronic, degenerative autoimmune disease of the central nervous system has a longitudinal and heterogeneous course with increasing treatment options and risk profiles requiring constant monitoring...

This study developed 24 measurable quality indicators (QIs) for monitoring multiple sclerosis care through literature review and expert consensus, aiming to enhance patient management and treatment outcomes.

  • Saved

1yr
Metabolomics in systemic sclerosis

Metabolomics in systemic sclerosis

Source : https://pubmed.ncbi.nlm.nih.gov/38981905/

Systemic sclerosis is a rare autoimmune condition leading to incurable complications. Therefore fast and precise diagnosis is crucial to prevent patient death and to maintain quality of life. Unfortunately, currently...

Metabolomic studies reveal significant differences between systemic sclerosis patients and controls; however, inconsistencies and inadequate patient descriptions necessitate further research for reliable biomarker identification and enhanced diagnostic accuracy.